US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Market Highlights: Spain Bipolar Disorder – 2014
5/1/2014 | published by: Fore Pharma
... research includes Spain bipolar disorder market size estimates for 2013, market share forecast for six years to 2019, bipolar disorder drugs market share, bipolar disorder drugs sales estimates, bipolar disorder drugs sales forecast, and bipolar ...  |  read more...
USD 990
Market Highlights: US Bipolar Disorder – 2014
5/1/2014 | published by: Fore Pharma
... US. The research includes the US bipolar disorder market size estimates for 2013, market share forecast for six years to 2019, bipolar disorder drugs market share, bipolar disorder drugs sales estimates, bipolar disorder drugs sales ...  |  read more...
USD 990
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Low-Grade Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Low-Grade Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Low-Grade Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Malignant Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Malignant Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Pontine Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Pontine Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Global Depression Drugs Market 2014-2018
1/17/2014 | published by: TechNavio - Infiniti Research Ltd.
... growth is the increase in the number of patients suffering from depression. The Global Depression Drugs market has also been witnessing the growing awareness of depression drugs. However, the generic erosion of key blockbuster drugs ...  |  read more...
USD 2,500
EpiCast Report: Migraine - Epidemiology Forecast to 2023
2/10/2014 | published by: GlobalData
... vomiting; and increased sensitivity to light, sound and smell (Bigal and Lipton, 2006). Because migraine is one of the most prevalent types of headache, there is a substantial economic and social burden associated with the ...  |  read more...
USD 3,995
Brain Metastasis Global Clinical Trials Review, H1, 2014
2/26/2014 | published by: GlobalData
... information and data relating to the clinical trials on Brain Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Brain Cancer Global Clinical Trials Review, H1, 2014
2/26/2014 | published by: GlobalData
... information and data relating to the clinical trials on Brain Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Schizophrenia - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Schizophrenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Clozaril (Schizophrenia) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have estimated that roughly 24 million people are affected by schizophrenia worldwide. While the ...  |  read more...
USD 3,495
Fanapt (Schizophrenia) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have estimated that roughly 24 million people are affected by schizophrenia worldwide. While the ...  |  read more...
USD 3,495
Market Highlights: Spain Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... hyperactivity disorder drug sales forecast in Spain. The research includes Spain attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder drugs market share, ...  |  read more...
USD 990
Market Highlights: Germany Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... hyperactivity disorder drug sales forecast in Germany. The research includes Germany attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder drugs market share, ...  |  read more...
USD 990
Market Highlights: France Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... hyperactivity disorder drug sales forecast in France. The research includes France attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder drugs market share, ...  |  read more...
USD 990
Market Highlights: Japan Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... hyperactivity disorder drug sales forecast in Japan. The research includes Japan attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder drugs market share, ...  |  read more...
USD 990
Market Highlights: Europe Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... disorder drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six ...  |  read more...
USD 2,800
Market Highlights: Spain Schizophrenia – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: France Schizophrenia – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: US Schizophrenia – 2014
5/1/2014 | published by: Fore Pharma
... the US schizophrenia market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.This research ...  |  read more...
USD 990
EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022
11/15/2013 | published by: GlobalData
... motivation. Schizophrenia affects men and women equally, and usually starts in young adulthood (between ages 16 and 30 years). Due to the chronic nature of the condition, schizophrenia requires lifelong treatment. Although treatment helps in ...  |  read more...
USD 3,995
EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022
11/15/2013 | published by: GlobalData
... with men and most commonly affects people ages 50 years and older. Globally the diagnosed incidence of trigeminal neuralgia varies between 4.3 cases per 100,000 person-years in Rochester, Minnesota, US, and approximately 28.9 cases per ...  |  read more...
USD 3,995
Medulloblastoma Global Clinical Trials Review, H2, 2013
12/30/2013 | published by: GlobalData
... relating to the clinical trials on Medulloblastoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Investigation Report on China Aripiprazole Market, 2009-2018
3/6/2014 | published by: China Research and Intelligence Co., Ltd.
... Statistics shows that by the end of 2013 there have been over 10 million schizophrenia patients in China, and the number is still increasing year after year. Schizophrenia is a chronic persistent disease with recurrent ...  |  read more...
USD 1,800
3  4  5  6    8    10  11  12